Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 18-Sep-24
Select bar for recommendation details.
Recommendations | 18-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 8 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Rhythm Pharmaceuticals Inc have a median target of 56.50, with a high estimate of 77.00 and a low estimate of 48.00. The median estimate represents a 3.57% increase from the last price of 54.55.
High | 41.2% | 77.00 |
Med | 3.6% | 56.50 |
Low | -12.0% | 48.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | -35.98% |
Average growth rate | -16.22% |
More ▼
Revenue history & estimates in USD
Average growth rate | +10.97% |
Average growth rate | +292.34% |
More ▼